These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 10733261)

  • 1. Management of chronic lymphocytic leukaemia.
    Kalil N; Cheson BD
    Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving optimal outcomes in chronic lymphocytic leukaemia.
    Hamblin TJ
    Drugs; 2001; 61(5):593-611. PubMed ID: 11368285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
    Kimby E; Brandt L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):224-30. PubMed ID: 11441934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging treatments for chronic lymphocytic leukaemia.
    Robak T; Jamroziak K; Robak P
    Drugs; 2009; 69(17):2415-49. PubMed ID: 19911856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
    Chow KU; Kim SZ; von Neuhoff N; Schlegelberger B; Stilgenbauer S; Wunderle L; Cordes HJ; Bergmann L
    Eur J Haematol; 2011 Nov; 87(5):426-33. PubMed ID: 21749447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia.
    Keating MJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):107-14. PubMed ID: 10561025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL.
    Binet JL
    Baillieres Clin Haematol; 1993 Dec; 6(4):867-78. PubMed ID: 8038494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic lymphocytic leukemia].
    Maurer C; Hallek M
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
    Robak T
    Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.
    Schriever F; Huhn D
    Drugs; 2003; 63(10):953-69. PubMed ID: 12699399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
    J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches to the treatment and management of chronic lymphocytic leukaemia.
    Montserrat E; Rozman C
    Drugs; 1994; 47 Suppl 6():1-9. PubMed ID: 7525184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
    Solh M; Rai KR; Peterson BL; Kolitz JE; Appelbaum FR; Tallman MS; Belch A; Larson RA; Morrison VA
    Leuk Lymphoma; 2013 Feb; 54(2):252-4. PubMed ID: 22897733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines for alemtuzumab treatment in chronic lymphocytic leukaemia (CLL)].
    Smolej L; Procházka V; Špaček M; Obrtlíková P; Gumulec J; Vokurka S; Doubek M;
    Vnitr Lek; 2012 Mar; 58(3):232-6. PubMed ID: 22486291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.
    Robak T
    Leuk Lymphoma; 2002 Mar; 43(3):537-48. PubMed ID: 12002757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
    Robak T; Kasznicki M
    Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
    Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
    Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.